Swiss medtech/pharma companies:

“The opportunity and challenges on the Chinese market"

 

 

 

 

 

 

The Swiss Centers China in collaboration with Widler & Schiemann WSQMS invite you to join the conference and learn about the realities of the Chinese market in the field of pharma/medtech: CFDA regulatory, Clinical Trial, Distribution, Innovation and IP. 

 

 

Information

 

Date & Time:

26 March 2020 @ 17:45

 

Venue:

Microcity l Pierre-à-Mazel 39 l 2000 Neuchâtel

 

 

 

 

 

Agenda

18h00 – 18h05

Welcome words by Mrs. Aline Ballaman-Garibian

General Manager of the Swiss Centers China

18h05 – 18h30  

Macro picture of the business environment in China

Mr. Zhen Xiao, CEO of the Swiss Centers China

18h30 – 19h15  

The Chinese medtech/pharma market, Challenges and Opportunities for foreign companies 

Dr. Beat Widler, co-founder and managing director of WSQMS

Q&A

19h15

Networking cocktail

 

 

 

Speakers

 

 

 

Mr. Zhen Xiao is of Chinese origin, and lives in Switzerland since 2002. He obtained his engineering education in Nanyang Technological University, Singapore, with a first-class honor degree. He then worked in Singapore, Switzerland and China for more than 18 years as engineer, researcher, and managers. He has been working with the Swiss Federal Institute of Technology, Lausanne (EPFL) for over 10 years as China Relation Coordinator. Since 2010, he has been heading the non-profit organization, Foundation Swiss Centers, who facilitates Swiss companies’ trade and business development in China. In the past 4 years, Swiss Centers has set up 3 facilities in Shanghai and in Tianjin, and since it was founded in 2002, it supported more than 300 Swiss companies for their business development in China.

 

 

Dr. Beat Widler is a Ph.D. graduate from the Swiss Federal Institute of Technology in Zurich (ETH), and holds the Swiss Diploma of Pharmaceutical Medicine. He operates as an independent CQA, quality risk management, GCP and pharmacovigilance auditing expert and is managing partner at Widler & Schiemann AG in Zug. Dr. Widler has over 25 years with Roche in Switzerland and the UK in the areas of regulatory affairs, clinical research and Quality Assurance & Risk Management. For 15 years, he was Global Head of Roche Clinical Quality and 5 years the Head of Roche Clinical Development UK. Representative for more than 15 years on IFPMA, EFPIA, Interpharma working groups and delegations to Health Authorities.

 

 

 

 

 

 

 

Register For Free

 

 

 

 

 

 

 

For registration, please contact: Ms. Claire Hu claire.hu@swisscenters.org

 with name, company, position

The seats are limited to industry related guests. Thank you very much for your understanding.

 

 

 

© SWISS CENTERS CHINA 2020

The Swiss Centers are invested and developed by Foundation Swiss Centers, a non-profit foundation registered in Neuchâtel, Switzerland.

 

 

 

 

 

 

 

 

 

IN CHINA

HEADQUARTERS

A301 BLDG 3 526 FUTE NO.3 RD

SHANGHAI PILOT FREE TRADE ZONE

IN SWITZERLAND

AVENUE DE CHAMPS-MONTANTS 12B

2074 MARIN

NEUCHATEL

wechat-logo-preview

code

Scan QR code

to follow us on WeChat

扫描二维码关注我们

 

www.swisscenters.org | admin@swisscenters.org

Call us: +86 21 2076 5593

 

 

 

 

 

 

 

 

 

 

This email was sent to you because you are in the Swiss Centers China network. Send us a message if you wish to unsubscribe.